doi: 10.5732/cjc.011.10315

Reversing multidrug resistance by tyrosine kinase inhibitors

Miao He, Min-Jie Wei

Department of Pharmacology, Pharmaceutical College of China Medical University, Shenyang, Liaoning 110001, P. R. China.

[Abstract] Recently, a large number of tyrosine kinase inhibitors(TKIs) have been developed as anticancer agents. These TKIs can specifically and selectively inhibit tumor cell growth and metastasis by targeting various tyrosine kinases and thereby interfering with cellular signaling pathways. The therapeutic potential of TKIs has been hindered by multidrug resistance(MDR), which is commonly caused by overexpression of ATP-binding cassette(ABC) membrane transporters. Interestingly, some TKIs have also been found to reverse MDR by directly inhibiting the function of ABC transporters and enhancing the efficacy of conventional chemotherapeutic drugs. In this review, we discuss ABC transporter-mediated MDR to TKIs and MDR reversal by TKIs.

Chinese Journal of Cancer 2012, Volume: 31, Issue 3, Page: 126-133

[ PDF Full-text ]
[ Html full-text ](PubMed Central)
[ PubMed ]
[Google Scholar]

Cite this article

Miao He, Min-Jie Wei. Reversing multidrug resistance by tyrosine kinase inhibitors. Chin J Cancer. 2012, 31(3):126-133. doi:10.5732/cjc.011.10315


Export citations

EndNote